Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells Ex vivo

Viral Immunology

Volumn 24, Issue 4, 2011, Pages 281-289

  Nyakeriga, Alice M ^a   Ying, Jun ^b   Shire, Norah J ^b   Fichtenbaum, Carl J ^b   Chougnet, Claire A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ATAZANAVIR; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD69 ANTIGEN; DIDANOSINE; EFAVIRENZ; ENFUVIRTIDE; FOSAMPRENAVIR; INTERLEUKIN 12; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; MESSENGER RNA; NEVIRAPINE; OX40 LIGAND; STAVUDINE; TENOFOVIR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; RECEPTOR UPREGULATION; RNA EXTRACTION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD40 LIGAND; FEMALE; HIV; HIV INFECTIONS; HUMANS; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OX40 LIGAND; STAPHYLOCOCCUS AUREUS; VIRAL LOAD; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS; STAPHYLOCOCCUS AUREUS;

EID: 80051713713     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2010.0142     Document Type: Article

References (39)

1. Angel JB, Kumar A, Parato K, et al.: Improvement in cellmediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J Infect Dis 1998;177:898-904. (Pubitemid 28155141)
2. Angel JB, Parato KG, Kumar A, et al.: Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression. J Infect Dis 2001;183: 546-554. (Pubitemid 32147510)
3. Battegay M, Nuesch R, Hirschel B, and Kaufmann GR: Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 2006;6:280-287.
4. Bebell LM, Passmore JA, Williamson C, et al.: Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J Infect Dis 2008;198:710-714.
5. Bocchino M, Ledru E, Debord T, and Gougeon ML: Increased priming for interleukin-12 and tumour necrosis factor alpha in CD64 monocytes in HIV infection: modulation by cytokines and therapy. AIDS 2001;15:1213-1223. (Pubitemid 32592354)
6. Byrnes AA, Harris DM, Atabani SF, Sabundayo BP, Langan SJ, Margolick JB, and Karp CL: Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy. J Leukoc Biol 2008;84:1447-1453. (Pubitemid 352774479)
7. Chirmule N, McCloskey TW, Hu R, Kalyanaraman VS, and Pahwa S: HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J Immunol 1995;155:917-924.
8. Chougnet C: Role of CD40 ligand dysregulation in HIVassociated dysfunction of antigen-presenting cells. J Leukoc Biol 2003;74:702-709. (Pubitemid 38040346)
9. Chougnet C, Jankelevich S, Fowke K, et al.: Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDS. J Infect Dis 2001;184:201-205. (Pubitemid 32614051)
10. Chougnet C, Thomas E, Landay AL, Kessler HA, Buchbinder S, Scheer S, and Shearer GM: CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients. Eur J Immunol 1998;28:646-656. (Pubitemid 28101742)
11. D'Ambrosio D, Cantrell DA, Frati L, Santoni A, and Testi R: Involvement of p21ras activation in T cell CD69 expression. Eur J Immunol 1994;24:616-620.
12. D'Amico R, Yang Y, Mildvan D, et al.: Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067. J Clin Immunol 2005;25:106-115. (Pubitemid 40576722)
13. Dohnal AM, Luger R, Paul P, Fuchs D, and Felzmann T: CD40 ligation restores type 1 polarizing capacity in TLR4- activated dendritic cells that have ceased interleukin-12 expression. J Cell Mol Med 2009;13:1741-1750.
14. Donaghy H, Stebbing J, and Patterson S:. Antigen presentation and the role of dendritic cells in HIV. Curr Opin Infect Dis 2004;17:1-6. (Pubitemid 39089966)
15. Dybul M, Mercier G, Belson M, et al.: CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness. J Immunol 2000;165:1685-1691. (Pubitemid 30604608)
16. Frasca L, Nasso M, Spensieri F, Fedele G, Palazzo R, Malavasi F, and Ausiello CM: IFN-gamma arms human dendriticcells to perform multiple effector functions. J Immunol 2008;180:1471-1481.
17. Grewal IS, and Flavell RA: CD40 and CD154 in cellmediated immunity. Annu Rev Immunol 1998;16:111-135.
18. Harrison TS, and Levitz SM: Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J Immunol 1996;156:4492-4497. (Pubitemid 26165852)
19. Kornbluth RS: The emerging role of CD40 ligand in HIV infection. J Leukoc Biol 2000;68:373-382.
20. Kornbluth RS: An expanding role for CD40L and other tumor necrosis factor superfamily ligands in HIV infection. J Hematother Stem Cell Res 2002;11:787-801. (Pubitemid 35215914)
21. Lange CG, Lederman MM, Medvik K, Asaad R, Wild M, Kalayjian R, and Valdez H: Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS 2003;17:2015-2023. (Pubitemid 37297149)
22. Lange CG, Valdez H, Medvik K, Asaad R, and Lederman MM: CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clin Immunol 2002;102:154-161. (Pubitemid 34171514)
23. Lederman HM, Williams PL, Wu JW, et al.: Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virusinfected patients with severe CD4+ cell depletion. J Infect Dis 2003;188:1794-1803. (Pubitemid 38064863)
24. Matsumura Y, Hori T, Kawamata S, Imura A, and Uchiyama T: Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J Immunol 1999;163:3007-3011. (Pubitemid 29431795)
25. Meyaard L, Hovenkamp E, Pakker N, van der Pouw Kraan TC, and Miedema F: Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virusinfected individuals studied in relation to IL-10 and prostaglandin E2 production. Blood 1997;89:570-576. (Pubitemid 27051693)
26. Monari C, Casadevall A, Baldelli F, Francisci D, Pietrella D, Bistoni F, and Vecchiarelli A: Normalization of anticryptococal activity and interleukin-12 production after highly active antiretroviral therapy. AIDS 2000;14:2699-2708. (Pubitemid 32118723)
27. Nilsson J, Kinloch-de-Loes S, Granath A, Sonnerborg A, Goh LE, and Andersson J: Early immune activation in gutassociated and peripheral lymphoid tissue during acute HIV infection. AIDS 2007;21:565-574.
28. Nyakeriga AM, Fichtenbaum CJ, Goebel J, Nicolaou SA, Conforti L, and Chougnet CA: Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection. J Virol 2009;83:1193-1200.
29. Rosenblatt HM, Stanley KE, Song LY, Johnson GM, Wiznia AA, Nachman SA, and Krogstad PA: Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection. J Infect Dis 2005;192: 445-455. (Pubitemid 41023123)
30. Schweneker M, Favre D, Martin JN, Deeks SG, and McCune JM: HIV-induced changes in T cell signaling pathways. J Immunol 2008;180:6490-6500.
31. Snijders A, Hilkens CM, van der Pouw Kraan TC, Engel M, Aarden LA, and Kapsenberg ML: Regulation of bioactive IL- 12 production in lipopolysaccharide- stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol 1996;156:1207-1212. (Pubitemid 26048118)
32. Snijders A, Kalinski P, Hilkens CM, and Kapsenberg ML: High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998;10:1593-1598. (Pubitemid 28502373)
33. Subauste CS, Wessendarp M, Portilllo JA, et al.: Pathogenspecific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients. J Infect Dis 2004;189:61-70. (Pubitemid 38122330)
34. Subauste CS, Wessendarp M, Smulian AG, and Frame PT: Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection. J Infect Dis 2001;183:1722-1731. (Pubitemid 32523234)
35. Valdez H, Connick E, Smith KY, et al.: Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease. AIDS 2002; 16:1859-1866.
36. van Kooten TG, Klein CL, and Kirkpatrick CJ: Cell-cycle control in cell-biomaterial interactions: expression of p53 and Ki67 in human umbilical vein endothelial cells in direct contact and extract testing of biomaterials. J Biomed Mater Res 2000;52:199-209. (Pubitemid 30490998)
37. Vanham G, Penne L, Devalck J, et al.: Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol 1999;117:335-342. (Pubitemid 29355090)
38. Zhang R, Fichtenbaum CJ, Hildeman DA, Lifson JD, and Chougnet C: CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription. J Immunol 2004;172:2678-2686. (Pubitemid 38182420)
39. Zhang R, Lifson JD, and Chougnet C: Failure of HIVexposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions. Blood 2006;107: 1989-1995. (Pubitemid 43289382)